Intelligence Platform
Patents
Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7718610
Retrocyclins: antiviral and antimicrobial peptides
granted patentUS 7718386
Methods for the diagnosis of diabetes
granted patentUS 7718781
Hydroxypyridonate and hydroxypyrimidinone chelating agents
granted patentUS 7718684
Methods and materials for assessing prostate cancer therapies and compounds
granted patentUS 7713927
Antimicrobial peptides
granted patentUS 7713721
Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pai
granted patentUS 7713526
Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell car
granted patentUS 7714014
Targeting GLI proteins in human cancer by small molecules
granted patentUS 7713939
Illudin analogs useful as antitumor agents
granted patentUS 7709517
Diarylhydantoin compounds
granted patentUS 7704701
Diagnosis of prostate cancer with SPAS-1 cancer antigen
granted patentUS 7705164
Metalloprotein inhibitors
granted patentUS 7700127
Method and compositions for preparing and delivering rumen protected lipids, other nutrien
granted patentUS 7700738
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted patentUS 7700547
Preventing airway mucus production by administration of EGF-R antagonists
granted patentUS 7696244
Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof
granted patentUS 7696227
Small-molecule inhibitors of the androgen receptor
granted patentUS 7691965
Helical synthetic peptides that stimulate cellular cholesterol efflux
granted patentUS 7691607
Expression system of NELL peptide
granted patentUS 7687462
Composition for promoting cartilage formation or repair comprising a nell gene product and
granted patentUS 7687480
Phosphonate compounds
granted patentUS 7687506
Selective serine/threonine kinase inhibitors
granted patentUS 7683041
Microgel particles for the delivery of bioactive materials
granted patentUS 7682607
Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell car
granted